Publication Name	World Journal of Nephrology
Manuscript ID	12189
Country	United States

Received	2014-06-26 08:20
Peer-Review Started	2014-06-26 17:07
To Make the First Decision	2014-08-14 14:37
Return for Revision	2014-08-18 10:01
Revised	2014-08-30 01:10
Second Decision	2014-10-16 15:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-10-16 16:03
Articles in Press	2014-10-16 16:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-23 09:52
Publish the Manuscript Online	2014-11-07 16:40

ISSN	2220-6124 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs
Manuscript Source	Invited Manuscript
All Author List	Hudaifa Alani, Asad Tamimi and Nihad Tamimi
Funding Agency and Grant Number
Corresponding Author	Dr. Nihad Tamimi, MBBS, MSc, FRCP, Pfizer Worldwide Research and Development, Pfizer Inc, 610 Main Street, Cambridge, MA 02139, United States. nihad.tamimi@pfizer.com
Key Words	Cardiovascular disease; Chronic kidney disease; Risk factors; Inflammation
Core Tip	Chronic kidney disease (CKD) has been recognised as a health concern globally and leads to high morbidity, mortality and healthcare expenditure. CKD is an independent risk factor for several different unfavourable outcomes including cardiovascular disease (CVD). Traditional and non-traditional risk factors for CVD exist in patients with CKD. Non-traditional risk factors of CKD are mainly uraemia-specific and include release of large levels of inflammatory and prothrombotic factors, low levels of haemoglobin, albuminuria, and abnormal bone and mineral metabolism. Future research is warranted to delineate clear evidence to the benefit of modifying non-traditional risk factors
Publish Date	2014-11-07 16:40
Citation	Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014; 3(4): 156-168
URL	http://www.wjgnet.com/2220-6124/full/v3/i4/156.htm
DOI	http://dx.doi.org/10.5527/wjn.v3.i4.156

Full Article (PDF)	WJN-3-156.pdf
Full Article (Word)	WJN-3-156.doc
Manuscript File	12189-Review.doc
Answering Reviewers	12189-Answering reviewers.pdf
Copyright License Agreement	12189-Copyright assignment.pdf
Peer-review Report	12189-Peer review(s).pdf
Scientific Misconduct Check	12189-CrossCheck.jpg
Scientific Editor Work List	12189-Scientific editor work list.pdf